Effects of estradiol benzoate on 5'-iodothyronine deiodinase activities in female rat anterior pituitary gland, liver and thyroid gland

• Published in: Brazilian journal of medical and biological research Vol. 30; no. 12; pp. 1479 - 1484
• Main Authors: Lisbôa, P C, Curty, F H, Moreira, R M, Pazos-Moura, C C
• Format: Journal Article
• Language: English
• Published: Brazil Associação Brasileira de Divulgação Científica 01-12-1997
• Subjects: 5'-iodothyronine deiodinase; Analysis of Variance; Animals; BIOLOGY; estradiol; Estradiol - analogs & derivatives; Estradiol - pharmacology; Female; In Vitro Techniques; Iodide Peroxidase - analysis; Iodide Peroxidase - drug effects; Liver - drug effects; Liver - enzymology; MEDICINE, RESEARCH & EXPERIMENTAL; Microsomes; Ovariectomy; Pituitary Gland, Anterior - drug effects; Pituitary Gland, Anterior - enzymology; Rats; Rats, Wistar; Thyroid Gland - drug effects; Thyroid Gland - enzymology; thyrotropin; thyroxine; Thyroxine - analysis; triiodothyronine; Triiodothyronine - analysis; thyroxine; thyrotropin; 5'-iodothyronine deiodinase; triiodothyronine; ovariectomy; estradiol
• ISSN: 0100-879X; 1414-431X; 0100-879X; 1414-431X
• DOI: 10.1590/S0100-879X1997001200016

There is little information on the possible effects of estrogen on the activity of 5'-deiodinase (5'-ID), an enzyme responsible for the generation of T3, the biologically active thyroid hormone. In the present study, anterior pituitary sonicates or hepatic and thyroid microsomes from ovariectomized (OVX) rats treated or not with estradiol benzoate (EB, 0.7 or 14 micrograms/100 g body weight, s.c., for 10 days) were assayed for type I 5'-ID (5'-ID-I) and type II 5'-ID (5'-ID-II, only in pituitary) activities. The 5'-ID activity was evaluated by the release of 125I from deiodinated 125I rT3, using specific assay conditions for type I or type II. Serum TSH and free T3 and free T4 were measured by radioimmunoassay. OVX alone induced a reduction in pituitary 5'-ID-I (control = 723.7 +/- 67.9 vs OVX = 413.9 +/- 26.9; P < 0.05), while the EB-treated OVX group showed activity similar to that of the normal group. Thyroid 5'-ID-I showed the same pattern of changes, but these changes were not statistically significant. Pituitary and hepatic 5'-ID-II did not show major alterations. The treatment with the higher EB dose (14 micrograms), contrary to the results obtained with the lower dose, had no effect on the reduced pituitary 5'-ID-I of OVX rats. However, it induced an important increment of 5'-ID-I in the thyroid gland (0.8 times higher than that of the normal group: control = 131.9 +/- 23.7 vs OVX + EB 14 micrograms = 248.0 +/- 31.2; P < 0.05), which is associated with increased serum TSH (0.6-fold vs OVX, P < 0.05) but normal serum free T3 and free T4. The data suggest that estrogen is a physiological stimulator of anterior pituitary 5'-ID-I and a potent stimulator of the thyroid enzyme when employed at high doses.